TY - JOUR
T1 - Long-term treatment optimization in individuals with multiple sclerosis using disease-modifying therapies
T2 - A nursing approach
AU - Denis, Lorraine
AU - Namey, Marie
AU - Costello, Kathy
AU - Frenette, Jocelyne
AU - Gagnon, Nathalie
AU - Harris, Colleen
AU - Lowden, Diane
AU - McEwan, Lynn
AU - Morrison, Wendy
AU - Poirier, Josée
PY - 2004/1/1
Y1 - 2004/1/1
N2 - The introduction of disease-modifying therapies (DMTs) for multiple sclerosis (MS) over the last 7 years has had a significant effect on the management of those living with this disease. Initially, the focus of improving treatment outcomes was on ensuring adherence to therapy by managing drug-related adverse events. However, treatment adherence is only one facet of ensuring optimal health outcomes for patients using DMTs. Therefore, a group of 80 nurses from Canada and the United States (The North American MS Nurses’ Treatment Optimization Group) developed an evidence-based nursing approach to address the various factors involved in obtaining optimal patient outcomes. The goal of this nursing approach is to ensure the best possible clinical, subclinical, psychosocial, and quality-of-life outcomes for patients with MS using DMTs.
AB - The introduction of disease-modifying therapies (DMTs) for multiple sclerosis (MS) over the last 7 years has had a significant effect on the management of those living with this disease. Initially, the focus of improving treatment outcomes was on ensuring adherence to therapy by managing drug-related adverse events. However, treatment adherence is only one facet of ensuring optimal health outcomes for patients using DMTs. Therefore, a group of 80 nurses from Canada and the United States (The North American MS Nurses’ Treatment Optimization Group) developed an evidence-based nursing approach to address the various factors involved in obtaining optimal patient outcomes. The goal of this nursing approach is to ensure the best possible clinical, subclinical, psychosocial, and quality-of-life outcomes for patients with MS using DMTs.
UR - http://www.scopus.com/inward/record.url?scp=1842432687&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1842432687&partnerID=8YFLogxK
U2 - 10.1097/01376517-200402000-00003
DO - 10.1097/01376517-200402000-00003
M3 - Article
C2 - 2004050644
AN - SCOPUS:1842432687
SN - 0888-0395
VL - 36
SP - 10
EP - 22
JO - Journal of Neuroscience Nursing
JF - Journal of Neuroscience Nursing
IS - 1
ER -